CDER New October 23, 2015

What's New on the FDA Drugs Site

October 22, 2015

• Drug Approval Case Studies
• Drug Firm Annual Registration Status (updated)
• Drug Firm Annual Registration Status Download File (updated)
• FDA Drug Safety Communications:
  • FDA requires drug interaction studies with potassium-lowering drug Kayexalate (sodium polystyrene sulfonate)
  • FDA warns of serious liver injury risk with hepatitis C treatments Viekira Pak and Technivie
• National Drug Code Directory
• Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)